Welcome to Novo Nordisk in the United States


Policy & Advocacy

We believe that early detection and quality care are the elements necessary to extend and improve the lives of people living with diabetes, hemophilia, and growth hormone disorders. Our mission is to inform and influence policy to promote access to care for the patients we serve and to communicate the impact of healthcare reform. Through collaboration with federal agencies, policymakers, advocacy organizations and other internal and external stakeholders, we make it our goal to promote prevention and treatment efforts to ultimately turn best practices into public policy.